Lepsylief Launch
Brief Story
•Eva is launching a new product for Epilepsy (Lepsyleif)
•Introducing a new molecule “Eslicarbazepine acetate”, the 3rd and nouvelle molecule since after Oxcarbazepin and Caarbazepin.
•Eslicarbazepine has high efficacy, low S.E, and high compliance (taken once daily)
•Lacks the toxic epoxide of carbazepine
•Single minded message: The winning tool (high efficacy, low SE, high compliance)
Creative Concept
Lipsylief is the new way to ESCape from Epilepsy. (ESC) is the USPs of our product (Efficacy, Safety, Compliance)
Lepsylief… Epilepsy ESCape Key
*Efficacy, Safety, Compliance
